# Site TraceMap Tools Stakeholder Objection Guide Review Packet

Status: not-started
Readiness: ready-for-implementation
Public claim level: concept

## Review Objective

Review this spec-only packet for a future `tracemap.tools` stakeholder
objection guide. The future page or section should help managers, reviewers,
engineers, and skeptical stakeholders ask hard questions and receive bounded
answers: what TraceMap evidence can support, what it cannot support, and what
next owner or runtime evidence is needed.

This packet intentionally changes no site source, site scripts, scanner code,
reducer code, generated outputs, validation scripts, or public copy.

## Files In Scope

- `.kiro/specs/site-tracemap-tools-stakeholder-objection-guide/requirements.md`
- `.kiro/specs/site-tracemap-tools-stakeholder-objection-guide/design.md`
- `.kiro/specs/site-tracemap-tools-stakeholder-objection-guide/tasks.md`
- `.kiro/specs/site-tracemap-tools-stakeholder-objection-guide/implementation-state.md`
- `.kiro/specs/site-tracemap-tools-stakeholder-objection-guide/review-packet.md`

## Reviewer Questions

1. Does the spec make clear that the future guide is concept-level and must
   visibly say `Public claim level: concept`?
2. Does it require visible `No public conclusion without evidence`?
3. Does it require a final placement decision and rejected alternatives for
   `/objections/`, `/questions/objections/`, a section on `/questions/`, or a
   section on `/manager-faq/`?
4. Does it distinguish the guide from `/questions/`, `/manager-faq/`,
   `/limitations/`, `/static-vs-runtime/`, `/review-claim-checklist/`,
   `/proof-paths/tour/`, and `/manager-demo-script/` or
   `/demo/manager-script/` if present?
5. Does it include the required objection categories:
   `Does this prove runtime behavior?`,
   `Can I use this for release approval?`,
   `Does this show production traffic or endpoint performance?`,
   `Is this AI analysis?`,
   `Does missing evidence mean no impact?`,
   `Can I share raw artifacts?`,
   `Who owns the next answer?`, and
   `What do we do under reduced coverage?`
6. Does every objection require safe short answer, evidence to check, stop
   condition, next owner, public claim level, limitation/non-claim, and a link
   to a supporting public route?
7. Are forbidden runtime, production, endpoint-performance, outage-cause,
   release-safety, operational-safety, complete-coverage, AI/LLM, embedding,
   vector database, prompt-classification, autonomous-approval,
   release-approval, and absence-of-impact claims blocked clearly enough?
8. Does it prohibit raw facts, raw SQLite content, analyzer logs, raw source
   snippets, raw SQL, config values, secrets, local paths, raw remotes,
   generated scan directories, private sample names, raw command output,
   hidden validation details, and credential-like values?
9. Does the tone guidance make skepticism useful without blame or defensive
   copy?
10. Are future validation expectations specific enough for required objection
    rows, required links, metadata, discovery/sitemap metadata if standalone,
    forbidden claims, private/raw material, word count bounds, and
    desktop/mobile browser sanity?

## Required Review Commands

Run if available:

```bash
node scripts/kiro-review.mjs --phase site-tracemap-tools-stakeholder-objection-guide --kind spec --model claude-opus-4.8 --fresh --timeout-ms 600000 --save-review-text
node scripts/kiro-review.mjs --phase site-tracemap-tools-stakeholder-objection-guide --kind spec --model claude-sonnet-4.6 --fresh --timeout-ms 600000 --save-review-text
```

If a model or tool is unavailable, record the exact command and error in
`implementation-state.md`.

## Review Status

Initial review and re-review ran with `claude-opus-4.8` and
`claude-sonnet-4.6`. All runs had reduced coverage because Kiro reported
denied tool access; Sonnet metadata also recorded `reviewComplete: false`.

Medium or higher findings were patched or dispositioned. Remaining findings
are Low or residual review coverage risks recorded in
`implementation-state.md`. The spec is ready for a future implementation
phase; this branch remains spec-only.
